Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT02268669
Eligibility Criteria:
Inclusion Criteria:
* Age \>18 years
* Chest discomfort \> 30 minutes with no response to nitroglycerin
* Time from the onset of symptoms to randomization between 0 and 12 hours
* ST segment elevation \> 1 mm in two or more contiguos precordial leads or non-diagnostic ECG (left bundle branch block or pacemarker rhythm) with classic symptoms.
* Killip class equal or less than 3
* Written informed consent
Exclusion Criteria:
* Cardiogenic shock defined as a systolic blood pressure \<90 mm Hg without response to fluid administration or \<100 mm Hg in patients with supportive treatment and no bradycardia
* Suspicion or evidence of mechanical complications of STEMI
* Non-cardiac disease that is likely to jeopardize compliance with follow-up schedule of the study (life expectancy \< 1 year)
* woman of childbearing potential unless a negative pregnant test
* Major contraindications for thrombolytic therapy
* Participation in other trial
* Known multivessel disease identified as unsuitable for revascularization
* Known peripheral vascular disease that complicates cardiac catheterization
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02268669
Study Brief:
Protocol Section:
NCT02268669